Answers are grounded in this paper and cite their sources.
Background: The increasing occurrence of infections caused by carbapenem resistant Gram negative bacilli (CR GNB) has resulted in colistin being the last resort. But worldwide, there is an increase in resistance even to colistin, which necessitates accurate detection. This is impeded by a lack of reliable and user-friendly methods for colistin testing. Aims: To evaluate the performance of Vitek-2 colistin susceptibility testing for CR-GNB. Materials and Methods: A retrospective observational study was conducted in a tertiary care center, including 2245 CR-GNB isolates. Of these, both Vitek-2 minimum inhibitory concentration (MIC) and Broth microdilution (BMD) method data were available for 222 isolates, which were further analyzed. Comparison was done between the colistin MIC values obtained by Vitek-2 and BMD (gold standard). MICs were evaluated according to the CLSI M100-E33, and categorical agreement (CA), essential agreement (EA), major error (ME), and very ME (VME) rates were calculated. Results: Colistin resistance was found in 34 (1.51%) strains among the 2245 CR-GNB isolated in the study period. Pseudomonas aeruginosa had the highest (47.06%) colistin resistance, followed by Klebsiella pneumoniae (38.23%). Vitek-2 yielded EA and CA of 62.61% and 93.24%, respectively. There were 15 (6.85%) MEs, much more than the CLSI acceptable range. The highest percentage of ME was committed for Acinetobacter baumannii (33.33%). No isolate was misreported as sensitive by Vitek-2 (VME = 0). Conclusion: Colistin susceptibility testing remains a challenging task for laboratories. Although automated systems like Vitek-2 provide faster results, the colistin antimicrobial susceptibility testing results generated by them need to be validated by the BMD method.
No takes yet. Share an insight, caveat, or question.
Sharma et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: